A Call for Sharing: Adapting Pharmaceutical Research to New Realities

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Science Translational Medicine

• Publication date

  2009-12-02

• Fields of study

  Medicine, Business

• Identifiers
  DOI 10.1126/scitranslmed.3000155PMID 20368187
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Distributed Drug Discovery. Part 1. Linking Academia and Combinatorial Chemistry to Find Drug Leads for Developing World Diseases.

  2009cited by this paper
• Lessons from 60 years of pharmaceutical innovation

  2009cited by this paper
• Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery.

  2009cited by this paper
• Open access chemical and clinical probes to support drug discovery.

  2009cited by this paper
• Distributed Drug Discovery, Part 1: Linking Academia and Combinatorial Chemistry to Find Drug Leads for Developing World Diseases

  2008cited by this paper
• The Major Role of Clinicians in the Discovery of Off‐Label Drug Therapies

  2006cited by this paper
• Can open-source R&D reinvigorate drug research?

  2006cited by this paper

• Quantifying the Human Mortality Costs of Patent-based Intellectual Property: How Many Premature Deaths are due to Patents?

  2025cites this paper
• The Open Pharma Movement: Social Action to 'Open' Drug Research and Its Implications for Health.

  2025cites this paper
• Biopharmaceutical R&D outsourcing: short-term gain for long-term pain?

  2022cites this paper
• COVID-19 vaccines, public health goods and Catholic social teaching: Why justice must prevail over charity in the global vaccine distribution

  2022cites this paper
• How Do Drug Regulatory Bodies Deal With Potential Innovative Therapies?

  2020influential citation
• Models of Interaction Between Corporations and Start-Ups : A Legal

  2020cites this paper
• OPEN INNOVATION GROUNDWORK

  2020cites this paper
• One Step Into the Future: New iPSC Tools to Advance Research in Parkinson’s Disease and Neurological Disorders

  2019cites this paper
• How Do Drug Regulatory Bodies Deal With Potential Innovative Therapies?

  2019cites this paper
• Adaptation through Collaboration: Developing Novel Platforms to Advance the Delivery of Advanced Therapies to Patients

  2017cites this paper
• OPEN INNOVATION AS A FACILITATOR FOR CORPORATE EXPLORATION

  2017cites this paper
• Realizing Our Potential in Biobanking: Disease Advocacy Organizations Enliven Translational Research

  2016cites this paper
• Human Pluripotent Stem Cell‐Derived Cardiomyocytes

  2016cites this paper
• Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.

  2016cites this paper
• Ultrasound of alternating frequencies and variable emotional impact evokes depressive syndrome in mice and rats.

  2016cites this paper
• Patents and R&D expenditure effects on equity returns in pharmaceutical industry

  2016cites this paper
• Development and Validation of a Novel In Vitro Model for the Assessment of Heterocellular Interactions Mediated by Connexin43

  2015cites this paper
• A Historical View and Vision into the Future of the Field of Safety Pharmacology.

  2015cites this paper
• The Pharmaceutical Commons

  2015cites this paper
• Genomic and Viral Sovereignty: Tethering the Materials of Global Biomedicine

  2015cites this paper
• Emerging Technologies to Conserve Biodiversity.

  2015cites this paper
• Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 disease.

  2014cites this paper
• Alcohol medications development: advantages and caveats of government/academia collaborating with the pharmaceutical industry.

  2014cites this paper
• Divided We Fall

  2014cites this paper
• The determinants of attrition in drug development: a duration analysis

  2013cites this paper
• Perspectives and Opportunities for Precompetitive Public–Private Partnerships in the Biomedical Sector

  2013cites this paper
• Integrating human pluripotent stem cells into drug development.

  2013cites this paper
• Beyond Open Source: Patents, Biobanks and Sharing

  2013cites this paper
• Medications development to treat alcohol dependence: a vision for the next decade

  2012cites this paper
• Learning from Hackers: Open-Source Clinical Trials

  2012cites this paper
• Safety pharmacology in 2010 and beyond: survey of significant events of the past 10 years and a roadmap to the immediate-, intermediate- and long-term future in recognition of the tenth anniversary of the Safety Pharmacology Society.

  2011cites this paper
• Collaboration versus outsourcing: the need to think outside the box.

  2011cites this paper
• Innovative Partnerships for Drug Discovery against Neglected Diseases

  2011cites this paper
• Global translational medicine initiatives and programs

  2011cites this paper
• Looking to the future of research in pediatric anxiety disorders

  2011cites this paper
• How to Revive Breakthrough Innovation in the Pharmaceutical Industry

  2011cites this paper
• Biomedical research and health advances.

  2011cites this paper
• Opening Up to Precompetitive Collaboration

  2010cites this paper
• Role of open chemical data in aiding drug discovery and design.

  2010cites this paper
• Are Patents Impeding Medical Care and Innovation?

  2010cites this paper